BRIEF published on 07/02/2025 at 13:05, 1 year 3 months ago Bausch Health to Release Q2 2025 Financial Results Conference Call Investor Relations Financial Announcement Bausch Health Q2 2025 Results
PRESS RELEASE published on 07/02/2025 at 13:00, 1 year 3 months ago Bausch Health to Announce Second Quarter 2025 Results on July 30 Bausch Health Companies Inc. to release Q2 2025 financial results on July 30, 2025, followed by a conference call and webcast at 5:00 p.m. U.S. EDT. Details and materials available on the investor relations website Financial Results Conference Call Investor Relations Webcast Bausch Health
BRIEF published on 05/14/2025 at 22:20, 1 year 5 months ago Bausch Health Announces Election Results and Approvals at 2025 Annual Meeting Bausch Health Annual Meeting Shareholder Vote Director Election Compensation Approval
PRESS RELEASE published on 05/14/2025 at 22:15, 1 year 5 months ago Bausch Health Announces 2025 Annual Meeting of Shareholder Results Bausch Health Companies Inc. announces election of 10 directors at 2025 annual meeting of shareholders and various approvals and appointments Shareholders Bausch Health Companies Inc. Compensation Annual Meeting Election Of Directors
BRIEF published on 05/06/2025 at 14:05, 1 year 5 months ago Xifaxan Reduces Risk of 30-Day Rehospitalization After OHE XIFAXAN Chronic Liver Disease OHE Rehospitalization Claims-Based Analysis Lactulose
PRESS RELEASE published on 05/06/2025 at 14:00, 1 year 5 months ago Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization New analysis shows Xifaxan efficacy in reducing OHE rehospitalizations regardless of prior treatment. Data presented at DDW 2025 XIFAXAN Bausch Health Gastroenterology OHE Rehospitalizations
BRIEF published on 04/30/2025 at 22:10, 1 year 5 months ago Bausch Health Reports First-Quarter 2025 Results Financial Results EBITDA Revenue Growth Bausch Health First Quarter 2025
PRESS RELEASE published on 04/30/2025 at 22:05, 1 year 5 months ago Bausch Health Announces First Quarter 2025 Results Bausch Health Companies Inc. reports strong first quarter 2025 financial results with revenue growth, successful refinancing, and favorable court ruling. Company remains focused on profitable growth and shareholder value Financial Results Revenue Growth Shareholder Value Bausch Health First Quarter 2025
BRIEF published on 04/29/2025 at 14:05, 1 year 5 months ago Bausch Health Secures Health Canada Approval for Thermage FLX Thermage FLX Bausch Health Health Canada Aesthetic Technology Skin Tightening
PRESS RELEASE published on 04/29/2025 at 14:00, 1 year 5 months ago Bausch Health Announces Health Canada Clearance of Solta Medical's Thermage(R) FLX System Health Canada approves Thermage FLX, the latest non-invasive skin tightening system from Bausch Health's Solta Medical. Features enhanced comfort, smart technology, and versatile applications Thermage FLX Bausch Health Health Canada Skin Tightening Solta Medical
Published on 10/15/2026 at 16:10, 2 hours 45 minutes ago North Shore Announces Extension to Falcon Property Option Agreement and Resource Stock Digest Engagement
Published on 10/15/2026 at 15:15, 3 hours 40 minutes ago Gold Terra to Host Community Town Hall Meeting in Yellowknife on October 21, 2026
Published on 10/15/2026 at 14:31, 4 hours 24 minutes ago First Breach to Present at the 20th Annual LD Micro Main Event
Published on 10/15/2026 at 14:05, 4 hours 50 minutes ago Innodata to Report Third Quarter 2026 Results
Published on 10/15/2026 at 14:00, 4 hours 55 minutes ago Tectonic Metals Drills 2.41 g/t Au over 59.44 metres, Including 11.82 g/t Au over 10.67 metres and 39.96 g/t Au over 3.05 metres at Alpha Bowl, Flat Gold Project, Alaska
Published on 10/15/2026 at 18:03, 52 minutes ago AIXTRON Q3 2026: Order intake and operating profitability significantly exceed market expectations
Published on 10/15/2026 at 18:00, 55 minutes ago Supervisory Board appoints Dr. Marc-Alexander Mahl to the Fresenius Management Board and extends Sara Hennicken’s contract
Published on 10/15/2026 at 18:00, 55 minutes ago EQS-Adhoc: AIXTRON Q3 2026: Order intake and operating profitability significantly exceed market expectations
Published on 10/15/2026 at 18:50, 5 minutes ago September & first 9 months of 2026 traffic figures - Revision of Traffic assumptions for 2026
Published on 10/15/2026 at 17:45, 1 hour 10 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 10/15/2026 at 07:27, 11 hours 27 minutes ago Saint-Gobain strengthens its infrastructure offer in North America with the acquisition of D.S. Brown in construction chemicals
